Acetylsalicylic Acid Reduces the Severity of Dextran Sodium Sulfate-Induced Colitis and Increases the Formation of Anti-Inflammatory Lipid Mediators

Impact of acetylsalicylic acid on tumor angiogenesis and lymphangiogenesis through inhibition of VEGF signaling in a murine sarcoma model

(2013) XIAOYUE ZHANG et al.   ONCOLOGY REPORTS

Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production

(2011) David Prescott et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats

(2011) JF Lima-Garcia et al.   BRITISH JOURNAL OF PHARMACOLOGY

Aspirin and Low-Dose Nitric Oxide-Donating Aspirin Increase Life Span in a Lynch Syndrome Mouse Model

(2011) M. A. Mcilhatton et al.   Cancer Prevention Research

Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF- 

(2011) K. H. Weylandt et al.   CARCINOGENESIS

Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice

(2011) A. F. Bento et al.   JOURNAL OF IMMUNOLOGY

Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples

(2011) Beate Gomolka et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Novel Lipid Mediators Promote Resolution of Acute Inflammation

(2010) Matthew Spite et al.   CIRCULATION RESEARCH

Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6–STAT3 signaling pathway

(2010) Yun Tian et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

(2010) S. Krishnamoorthy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease

(2009) M W M D Lutgens et al.   BRITISH JOURNAL OF CANCER

Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress

(2009) M Spite et al.   BRITISH JOURNAL OF PHARMACOLOGY

Do Non-steroidal Anti-inflammatory Drugs Cause Exacerbations of Inflammatory Bowel Disease?

(2009) Linda A. Feagins et al.   DIGESTIVE DISEASES AND SCIENCES

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitis

(2009) Tsukasa Ishida et al.   INFLAMMATORY BOWEL DISEASES

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

(2009) Matthew Spite et al.   NATURE

Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease

(2008) Silvia Melgar et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Predicting and monitoring colitis development in mice by micro-computed tomography

(2007) Maria Fritsch Fredin et al.   INFLAMMATORY BOWEL DISEASES